Article thumbnail

Phosphatase-1-inhibitor-1: amplifier or attenuator of catecholaminergic stress?

By Katrin Wittköpper, Thomas Eschenhagen and Ali El-Armouche
Topics: Invited Editorial
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:2916120
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev 14:225–241
  2. (2004). Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.
  3. (2010). El-Armouche A
  4. (2005). Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ Res 96:756–766 570 Basic Res Cardiol
  5. (2010). Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonistinduced cardiac apoptosis. Basic Res Cardiol
  6. (2009). Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.
  7. (2007). Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart.
  8. (2008). Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
  9. (1998). Physiologic importance of protein phosphatase inhibitors.
  10. (2001). Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart. Basic Res Cardiol 96:528–538
  11. (2002). Type 1 phosphatase, a negative regulator of cardiac function.
  12. (2003). Unchanged G-protein-coupled receptor kinase activity in the aging human heart.